This is another example of cross-Atlantic collaboration in the Microbiome world, just as President Obama pledges €105M ($121M) to the up and coming field of therapeutics.
It’s a growing area of research, and as we spoke to Isabelle de Cremoux (founder of the biggest Microbiome fund in the World) last week, the past 12 months have seen a crazy surge in investment, research focus and new initiatives being founded on the Human Microbiome.
Ardigen is one such bioinformatics company to join this movement, based on combination of bio-data science and complementary advanced software support. Their services also include Laboratory information management systems (LIMS) and analytical tools for research.
On the other hand, EpiBiome, is a precision microbiome engineering company based in California.
EpiBiome’s mission is to develop effective and sustainable FDA-approved therapies to combat infectious disease in humans and in agriculture without the use of antibiotics.